Arkolith/Insider Trading/LENZ/Form 4

Olsson Shawn

Chief Commercial OfficerLENZ Therapeutics, Inc. (LENZ) · full profile →Form 4 · filed Nov 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$261K
Net Open-Market Flow
-$261K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2025Option exercise(M)10K$2.08$21K15K
Nov 17, 2025Sell(S)4K$25.74$108K11K
Nov 17, 2025Sell(S)6K$26.37$153K5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 17, 2025Option exercise(M)10K—$053K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002015796-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for LENZ Therapeutics, Inc.

Build

Ask your agent about LENZ insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0002015796-25-000003"
Ask your agent
Use Arkolith to summarize insider buying and selling at LENZ Therapeutics, Inc.
over the last 90 days and cite the filings.